Akums Drugs and Pharmaceuticals Limited has announced the cessation of Mr. Sunil Jaiswal as Senior Vice President – Research & Development and Senior Management Personnel. Mr. Jaiswal resigned due to personal family commitments, with his last day of employment being October 31, 2026. The company has provided details as per SEBI LODR Regulations, with Annexure-A detailing the change and Annexure-B containing his resignation letter.
Senior Management Change at Akums Drugs
Akums Drugs and Pharmaceuticals Limited has formally informed stakeholders about the resignation of Mr. Sunil Jaiswal from his position as Senior Vice President – Research & Development. Mr. Jaiswal was also designated as Senior Management Personnel of the Company. The company has accepted his resignation, which was submitted on August 5, 2026, and his services will cease on October 31, 2026.
Reason for Resignation
According to the notification, Mr. Jaiswal’s decision to resign stems from personal family commitments. The announcement also mentions that Mr. Jaiswal has attained the age of 61 years. The agreed-upon relieving date of October 31, 2026, was finalized after discussions, following his initial request to be relieved by October 30, 2026.
Regulatory Disclosures
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Akums Drugs and Pharmaceuticals Limited has provided necessary details regarding this change. The accompanying Annexure-A outlines the particulars of the cessation, including the reason and the effective date. Annexure-B contains a copy of Mr. Jaiswal’s resignation letter, dated August 5, 2026.
Source: BSE
